Integral Derivatives’s Exelon EXC Stock Holding History

Integral Derivatives’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-14,441	Closed	-$372K	–	1180
2017 Q2	$372K	Buy	+14,441	New	+$367K	0.01%	796
2016 Q1	–	Sell	-17,946	Closed	-$355K	–	929
2015 Q4	$355K	Hold	17,946	–	–	0.01%	749
2015 Q3	$380K	Hold	17,946	–	–	0.01%	791
2015 Q2	$402K	Buy	+17,946	New	+$430K	0.01%	782
2015 Q1	–	Sell	-26,778	Closed	-$708K	–	1176
2014 Q4	$708K	Hold	26,778	–	–	0.01%	796
2014 Q3	$651K	Sell	26,778 -70,100	-72%	-$1.64M	0.01%	876
2014 Q2	$2.52M	Buy	+96,878	New	+$2.47M	0.04%	338
2014 Q1	–	Sell	-47,668	Closed	-$931K	–	1388
2013 Q4	$931K	Buy	+47,668	New	+$959K	0.01%	807

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Integral Derivatives's EXC Position: Q2 2017 in Review

Integral Derivatives sold out of Exelon (EXC) in Q2 2017, closing a stake of 7,846 shares — an estimated $200K sold.

Integral Derivatives first reported a position in EXC in Q4 2013 and held it in 6 quarters. The position peaked at $1.4M in Q4 2013. 793 funds tracked by Wall St. Rank hold EXC as of Q2 2017.

Integral Derivatives reported no remaining Exelon position as of Q2 2017 after selling out during the quarter.
Integral Derivatives sold 7,846 Exelon shares in Q2 2017, an estimated $200K.
Integral Derivatives first reported a position in Exelon in Q4 2013 and held it in 6 quarters.
Integral Derivatives's Exelon position peaked at $1.4M in Q4 2013.
793 funds tracked by Wall St. Rank held Exelon as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.